Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
23.97
+0.41 (1.74%)
Mar 26, 2026, 3:04 PM CST

SHE:300357 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
12,33610,63915,18428,84930,00140,159
Market Cap Growth
5.60%-29.93%-47.37%-3.84%-25.29%73.73%
Enterprise Value
11,1099,54714,16027,83929,13739,393
Last Close Price
23.5620.0328.3253.5055.3873.96
PE Ratio
31.5933.4848.9582.7288.76144.22
Forward PE
30.6026.8038.4162.0969.5295.64
PS Ratio
11.7611.5017.9032.2037.1563.12
PB Ratio
4.524.336.5914.2316.7026.28
P/TBV Ratio
4.974.867.5015.6818.2728.79
P/FCF Ratio
49.9679.9298.21180.74126.95215.83
P/OCF Ratio
31.7040.5439.7480.0883.20156.74
EV/Sales Ratio
10.5910.3216.7031.0736.0761.92
EV/EBITDA Ratio
24.2326.4641.8569.1879.58133.68
EV/EBIT Ratio
27.8530.0846.1372.8684.20140.86
EV/FCF Ratio
44.9971.7291.59174.41123.29211.72
Debt / Equity Ratio
0.010.010.030.010.00-
Debt / EBITDA Ratio
0.040.070.180.040.02-
Debt / FCF Ratio
0.080.190.400.100.03-
Net Debt / Equity Ratio
-0.48-0.52-0.53-0.55-0.56-0.58
Net Debt / EBITDA Ratio
-2.93-3.57-3.62-2.78-2.77-3.02
Net Debt / FCF Ratio
-5.36-9.68-7.93-7.01-4.29-4.79
Asset Turnover
0.380.350.360.430.460.42
Inventory Turnover
0.940.770.750.830.680.67
Quick Ratio
14.138.588.4313.7211.7619.96
Current Ratio
14.789.058.8714.3812.4221.13
Return on Equity (ROE)
14.50%12.78%13.65%17.56%19.63%18.73%
Return on Assets (ROA)
8.91%7.53%8.06%11.56%12.23%11.53%
Return on Invested Capital (ROIC)
25.62%23.55%26.42%38.04%40.22%39.06%
Return on Capital Employed (ROCE)
14.40%12.60%12.90%18.20%19.00%18.10%
Earnings Yield
3.17%2.99%2.04%1.21%1.13%0.69%
FCF Yield
2.00%1.25%1.02%0.55%0.79%0.46%
Dividend Yield
0.93%1.10%0.65%0.37%0.36%0.22%
Payout Ratio
29.50%30.66%34.05%30.17%24.79%33.85%
Buyback Yield / Dilution
0.01%0.00%0.00%0.00%-0.00%0.00%
Total Shareholder Return
0.92%1.10%0.65%0.38%0.36%0.22%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.